1136 related articles for article (PubMed ID: 26530718)
1. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
2. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.
Cao H; Ren M; Guo L; Shang H; Zhang J; Song Y; Wang H; Wang B; Li X; Hu J; Wang X; Wang D; Chen J; Li S; Chen L
Trials; 2010 Mar; 11():27. PubMed ID: 20214831
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.
Lian F; Li G; Chen X; Wang X; Piao C; Wang J; Hong Y; Ba Z; Wu S; Zhou X; Lang J; Liu Y; Zhang R; Hao J; Zhu Z; Li H; Fang Liu H; Cao A; Yan Z; An Y; Bai Y; Wang Q; Zhen Z; Yu C; Wang CZ; Yuan CS; Tong X
J Clin Endocrinol Metab; 2014 Feb; 99(2):648-55. PubMed ID: 24432995
[TBL] [Abstract][Full Text] [Related]
5. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
[TBL] [Abstract][Full Text] [Related]
6. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.
Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G
Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075
[TBL] [Abstract][Full Text] [Related]
7. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
[TBL] [Abstract][Full Text] [Related]
8. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Chinese herbal medicine Jinqi Jiangtang Tablet on serum matrix metalloproteinase-9 level and its expression in peripheral blood monocytes of rats with diabetes mellitus].
Wang H; Shen L; Wang ZG; Cao Y
Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):442-6. PubMed ID: 21486558
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of effect of Jinqi Jiangtang Tablets on treating insulin resistance in type 2 diabetes].
Deng ZY; Wang MJ; Fan YH; Liu M
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):188-195. PubMed ID: 32237429
[TBL] [Abstract][Full Text] [Related]
11. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
[No Abstract] [Full Text] [Related]
12. JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial.
Wang H; Guo L; Shang H; Ren M; Wang X; Wang D; Chen J; Li S; Chen L; Wang Y; Liu Z; Zhai J; Song Y; Cao H; Zhang J; Liu C; Sun X; Huo D; Mu W; Zhang L; Zheng W; Yan X; Yao C
Sci Rep; 2017 Sep; 7(1):11190. PubMed ID: 28894283
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes.
Gao H; Yang Y; Deng J; Liang J; Zhang W; Feng X
Complement Ther Med; 2019 Dec; 47():102021. PubMed ID: 31780013
[TBL] [Abstract][Full Text] [Related]
14. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
Diabetes Prevention Program Research Group
Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial.
Ming J; Xu S; Liu C; Liu X; Jia A; Ji Q
Trials; 2018 Jan; 19(1):72. PubMed ID: 29373989
[TBL] [Abstract][Full Text] [Related]
16. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
17. JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.
Cao Y; Yao G; Sheng Y; Yang L; Wang Z; Yang Z; Zhuang P; Zhang Y
J Diabetes Res; 2019; 2019():1872134. PubMed ID: 30733971
[TBL] [Abstract][Full Text] [Related]
18. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
Anderson JM
J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
[TBL] [Abstract][Full Text] [Related]
19. A Chinese medicine formula (Jinqi Jiangtang Tablet): A review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications.
Liu Y; Wang A; Wen L; Yang Z; Yang X; Zhang X; Yan D
J Ethnopharmacol; 2019 May; 236():1-8. PubMed ID: 30802612
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.
Luo Y; Wang H; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Paul SK
J Diabetes Res; 2022; 2022():2971382. PubMed ID: 35036447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
